0 Commentarii
0 Distribuiri
614 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Anti-Dermatomycosis Skin Drugs Market Size and Growth ForecastAccording to the latest report published by Data Bridge Market Research, the Anti-Dermatomycosis Skin Drugs Market Data Bridge Market Research analyses that the global anti-dermatomycosis skin drugs market which was USD 16,240.00 million in 2022, is expected to reach USD 21,368.45 million by 2030, and is expected to undergo a CAGR of 3.49% during the forecast period of 2023 to 2030....0 Commentarii 0 Distribuiri 198 Views 0 previzualizare
-
Anti-hypertensive Drugs Market Growth, Analysis, Trends, Recent Developments and Forecast Analysis By Fact.MRRockville, Maryland – October 15, 2026 — The global anti-hypertensive drugs market is projected to grow from USD 27.0 billion in 2026 to USD 40.7 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.2% over the forecast period. According to the latest market analysis published by Fact.MR, demand is being supported by the rising burden of hypertension, broader...0 Commentarii 0 Distribuiri 342 Views 0 previzualizare
-
Anti-inflammatory Drugs Market Analysis with CAGR of 6.58% and Future OpportunitiesAnti-inflammatory Drugs Market Growth and Trends The global Anti-inflammatory Drugs Market is witnessing substantial growth, driven by the rising prevalence of chronic inflammatory diseases, increasing demand for pain management therapies, and advancements in pharmaceutical research. According to the latest report by Straits Research, the market was valued at USD 110.91 billion in 2022 and is...0 Commentarii 0 Distribuiri 902 Views 0 previzualizare
-
GCC Ophthalmic Drugs Market: Anti-Inflammatory Drugs and Glaucoma Drugs Leading the ChargeThe GCC Ophthalmic Drugs Market is experiencing significant and steady growth, with specific drug classes acting as primary catalysts. The market, valued at USD 1,122.12 Million in 2024, is projected to reach USD 2,201.84 Million by 2035, driven by the critical roles of these medications in managing prevalent and serious eye conditions. The Anti-Inflammatory...0 Commentarii 0 Distribuiri 394 Views 0 previzualizare
-
Why Is the Anti-Aging Medicinal Drugs Market Growing?Anti-aging medicinal drugs are pharmaceuticals designed to slow, prevent, or reverse age-related changes in the body. They include treatments for skin aging, hormonal changes, and age-related diseases. The global anti-aging medicinal drugs market is growing as populations age, awareness of age-related conditions increases, and research into longevity advances. The anti-aging medicinal drugs...0 Commentarii 0 Distribuiri 247 Views 0 previzualizare
-
Fluorine Triamcinolone Market Current Scenario and Future ProjectionsThe increasing prevalence of inflammatory skin disorders, respiratory conditions, and allergic diseases is significantly driving the growth of the fluorine triamcinolone market worldwide. Pharmaceutical manufacturers and healthcare providers are increasingly focusing on advanced corticosteroid therapies to improve patient outcomes and treatment efficiency. The global fluorine triamcinolone...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Global Diabetes Drugs Market Growing at 12.1% CAGR Through 2032According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Global Ibuprofen Market Growing at 2.9% CAGR Through 2032According to a new report from Intel Market Research, the global ibuprofen market was valued at USD 87.4 million in 2024 and is projected to grow from USD 89.9 million in 2025 to USD 106 million by 2032, exhibiting a steady CAGR of 2.9% during the forecast period (2025–2032). This growth is driven by the increasing global burden of chronic pain conditions and inflammatory diseases, rapid...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek